Role of lymphocytes in liver cancer
- PMID: 24498546
- PMCID: PMC3906418
- DOI: 10.4161/onci.26468
Role of lymphocytes in liver cancer
Abstract
Hepatocellular carcinoma (HCC) typically occurs in patients with chronic inflammatory liver diseases, such as viral hepatitis or (non-)alcoholic steatohepatitis. Inflammation appears indeed as a crucial factor in hepatocarcinogenesis. Nevertheless, sophisticated animal models and studies of human samples revealed that the HCC also elicits antitumor immune responses. Patrolling and infiltrating lymphocytes (e.g., NKT and T cells, respectively) can exert decisive functions in the transition from chronic hepatic inflammation to cancer as well as in antitumor immune responses. An improved understanding of the cellular and molecular mechanisms whereby inflammation promotes or restricts hepatocarcinogenesis will open new avenues for therapeutic approaches to liver cancer.
Keywords: DEN; HCC; NKT cells; hepatocellular carcinoma; liver fibrosis.
Figures
Similar articles
-
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell-Dependent Control of Senescence.Gastroenterology. 2019 May;156(6):1877-1889.e4. doi: 10.1053/j.gastro.2019.01.247. Epub 2019 Jan 30. Gastroenterology. 2019. PMID: 30710528
-
Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.J Cancer Res Clin Oncol. 2017 May;143(5):821-834. doi: 10.1007/s00432-017-2364-z. Epub 2017 Feb 25. J Cancer Res Clin Oncol. 2017. PMID: 28238064
-
Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer.Int J Mol Sci. 2020 Oct 6;21(19):7378. doi: 10.3390/ijms21197378. Int J Mol Sci. 2020. PMID: 33036244 Free PMC article. Review.
-
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.Gut. 2012 Dec;61(12):1733-43. doi: 10.1136/gutjnl-2011-301116. Epub 2012 Jan 20. Gut. 2012. PMID: 22267597 Free PMC article.
-
Stromal and Immune Drivers of Hepatocarcinogenesis.2019 Aug 6. In: Hoshida Y, editor. Hepatocellular Carcinoma: Translational Precision Medicine Approaches [Internet]. Cham (CH): Humana Press; 2019. Chapter 15. 2019 Aug 6. In: Hoshida Y, editor. Hepatocellular Carcinoma: Translational Precision Medicine Approaches [Internet]. Cham (CH): Humana Press; 2019. Chapter 15. PMID: 32078263 Free Books & Documents. Review.
Cited by
-
Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies.Int J Mol Sci. 2022 Dec 4;23(23):15292. doi: 10.3390/ijms232315292. Int J Mol Sci. 2022. PMID: 36499616 Free PMC article. Review.
-
Immune surveillance of liver cancer in non-alcoholic fatty liver disease: excess lipids cause CD4 T-cells loss and promote hepatocellular carcinoma development.Hepatobiliary Surg Nutr. 2016 Oct;5(5):433-437. doi: 10.21037/hbsn.2016.09.10. Hepatobiliary Surg Nutr. 2016. PMID: 27826559 Free PMC article. No abstract available.
-
In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma.Front Immunol. 2021 May 7;12:650486. doi: 10.3389/fimmu.2021.650486. eCollection 2021. Front Immunol. 2021. PMID: 34025657 Free PMC article. Review.
-
Platelet-to-lymphocyte, neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios are related to cancer-related fatigue and quality of life in patients with cancer: a cross-sectional study.BMJ Open. 2023 Dec 6;13(12):e075398. doi: 10.1136/bmjopen-2023-075398. BMJ Open. 2023. PMID: 38056937 Free PMC article.
-
Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy.J Clin Med. 2019 Oct 14;8(10):1676. doi: 10.3390/jcm8101676. J Clin Med. 2019. PMID: 31614976 Free PMC article.
References
-
- Iavarone M, Cabibbo G, Piscaglia F, Zavaglia C, Grieco A, Villa E, Cammà C, Colombo M, SOFIA (SOraFenib Italian Assessment) study group Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. Hepatology. 2011;54:2055–63. doi: 10.1002/hep.24644. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources